Science News & Science Current Events
 
Email a Friend Send to a friend
Printer Friendly Print Effective cancer immune therapy through order in the blood vessels

Effective cancer immune therapy through order in the blood vessels

April 22, 2008

Immune therapies are considered very promising in cancer medicine: Tumor-fighting immune cells are supposed to invade tumor tissue and eliminate cancer cells right there. Although this works well in the test tube, clinical application often fails because immune cells are unable to get into the tumor tissue from the bloodstream in sufficient numbers.

This is due, among other things, to the 'chaotic' tumor vasculature: To get supplied with nutrients, a tumor stimulates the formation of new vessels. However, the architecture of these newly formed blood vessels differs from the normal one; they are poorly organized and regarded as immature. Therefore, in many tumors, immune cells have difficulty entering the cancer tissue. Studies show, however, that patients survive longer when immune cells are able to invade the tumor.




In an article published in Nature, scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Heidelberg University Hospitals, jointly with Australian researchers, have now described a key molecule that is responsible for the immature state of the tumor vasculature. In mice suffering from cancer whose gene encoding the Rgs5 signal protein is switched off, the investigators observed a normalization of blood vessels in the tumor. Tumor-specifically activated immune cells that were transplanted into these animals were found to colonize the cancer tissue in large numbers. In contrast, in mice with normal Rgs5 status, there is no significant invasion of immune cells into the tumor.

Survival rates clearly showed the success of the immune therapy: While some of the Rgs5-deficient animals were still alive after 48 weeks into the investigation, all animals with normal Rgs5 formation had died from cancer after 35 weeks at the latest. Vaccination with tumor-specific proteins also resulted in improved survival times of Rgs5-deficient mice, while it showed no effect in control animals.

"We were surprised that a gene that apparently affects vascular structure has such a strong influence on the success of immune therapies. Rgs5 is, thus, a completely new, promising target structure for clinical tumor therapy," says DKFZ's Professor Günter Hämmerling, one of the scientists leading the study. "But we don't necessarily have to knock out Rgs5 to improve the success of immune therapies. Available therapeutics that normalize tumor vasculature should also increase the invasion of immune cells into tumor tissue."

Juliana Hamzah, Manfred Jugold, Fabian Kiessling, Paul Rigby, Mitali Manzur, Hugo H. Marti, Tamer Rabie, Sylvia Kaden, Hermann-Josef Gröne, Günter J. Hämmerling, Bernd Arnold and Ruth Ganss: Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 2008, DOI: 10.1038/nature06868

The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to lead to new approaches in the prevention, diagnosis and treatment of cancer. The Center is financed to 90 percent by the Federal Ministry of Education and Research and to 10 percent by the State of Baden-Wuerttemberg. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V.).

Helmholtz Association of German Research Centres



Related Immune Cell Current Events and Immune Cell News Articles Immune Cell Current Events and Immune Cell News RSS Immune Cell Current Events and Immune Cell News RSS
MS patients have higher spinal fluid levels of suspicious immune molecule
A protein that helps keep immune cells quiet is more abundant in the spinal fluid of patients with multiple sclerosis (MS), further boosting suspicion that the protein, TREM-2, may be an important contributor to the disease.

Novel tuberculosis vaccine in Germany in clinical phase
For the first time in more than 80 years a promising live vaccine against tuberculosis has passed into the clinical phase in Germany: Since Monday of this week the new vaccine, which goes by the designation "VPM1002", has begun safety testing on volunteers in a Phase I clinical trial in Neuss, Germany.

Bone marrow stem cells may help control inflammatory bowel disease
Massachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model.

Personalized immunotherapy to fight HIV/AIDS
For a long time, the main obstacle to creating an AIDS vaccine has been the high genetic variability of the HIV virus. Dr. Jean-Pierre Routy and his team from the Research Institute of the McGill University Health Centre (MUHC), in collaboration with Dr. Rafick Sékaly from the Université de Montréal, have overcome this difficulty by designing a personalized immunotherapy for HIV-infected patients.

Leishmaniasis parasites evade death by exploiting the immune response to sand fly bites
Cutaneous leishmaniasis, a disease characterized by painful skin ulcers, occurs when the parasite Leishmania major, or a related species, is transmitted to a mammalian host by the bite of an infected sand fly.

Researchers disprove long-standing belief about HIV treatment
Researchers at Wake Forest University Baptist Medical Center have disproved a long-standing clinical belief that the hepatitis C virus slows or stunts the immune system's ability to restore itself after HIV patients are treated with a combination of drugs known as the "cocktail."

Plants make vaccine for treating type of cancer in Stanford study
Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.

Best treatment for MS may depend on disease subtype
Animal studies by University of Michigan scientists suggest that people who experience the same clinical signs of multiple sclerosis (MS) may have different forms of the disease that require different kinds of treatment.

Psychosocial issues affect HIV/AIDS treatment outcomes: UNC researcher
Psychosocial influences such as stress, depression and trauma have been neglected in biomedical and treatment studies involving people infected with HIV, yet they are now known to have significant health impacts on such individuals and the spread of AIDS, according to a University of North Carolina at Chapel Hill scientist.

Scientists discover how common vaccine booster works
In an online paper in the journal Nature, Yale University researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, explain how a common ingredient in many vaccines stimulates and interacts with the immune system to help provide protection against infectious diseases.
More Immune Cell Current Events and Immune Cell News Articles


Cell Communication in Nervous and Immune System (Results and Problems in Cell Differentiation)

At first glance, the nervous and immune systems appear very different. However, both systems have developed mechanisms for memory formation – though of quite different quality and significance for the organism. One striking example is that both systems form and communicate via synapses armed with similar sets of proteins. This collection of reviews, contributed by internationally recognized...

The Immune Functions of Epidermal Langerhans Cells (Medical Intelligence Unit)

Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections.(SYNOPSIS): An article from: Emerging Infectious Diseases
by Janie Parrino, Richard S. Hotchkiss, Mike Bray

This digital document is an article from Emerging Infectious Diseases, published by Thomson Gale on February 1, 2007. The length of the article is 5235 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Scientists gain new insights into immune-regulating cells.(RESEARCH NEWS)(Clinical report): An article from: Dermatology Nursing
by Daniel B. Burfeind

This digital document is an article from Dermatology Nursing, published by Thomson Gale on October 1, 2007. The length of the article is 504 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:...

B and t Cells in Immune Recognition
by F. Loor

Histophysiology of the Immune System: The Life History, Organization, and Interactions of Its Cell Populations (Advances in Experimental Medicine and Biology)

Mechanisms of Lymphocyte Activation and Immune Regulation Vi: Cell Cycle and Programmed Cell Death in the Immune System

University of California, Irvine. Proceedings from the sixth international conference held February 2-4, 1996, in Newport Beach, CA. DNLM: Apoptosis-physiology...

The Natural Killer Cell: The Natural Immune System

The ability of an organism to combat infection by foreign particles and microbial pathogens is essential for its survival and evolutionary success. Such efforts at immunity can take two forms. A considerable number of works have been published which focus on the central role of antigen recognition and antibody structure and function in the host response to infection. This volume, however,...

Natalizumab maintains remission in Crohn's; drug blocks immune cell movement.(News): An article from: Family Practice News
by Mitchel L. Zoler

This digital document is an article from Family Practice News, published by International Medical News Group on June 15, 2004. The length of the article is 1103 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...



Guide to Signal Pathways in Immune Cells
by E. Nigel Wardle

In Guide to Signal Pathways in Immune Cells, Nigel E. Wardle presents vital information in regards to white cells, like the neutrophils and macrophages, T and B lymphocytes, natural killer cells and mast cells, as they constitute the immune defenses against microbial invaders or tumor cells. In all such cells the necessary information processing for their activities utilizes a network of...

© 2008 BrightSurf.com